Comprehensive Forecast: AI In Bioinformatics Market Share, Growth, and Opportunities Through 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Industry Valuation for the AI In Bioinformatics Sector?
In recent times, the market size for AI in bioinformatics has experienced exponential growth. The projected growth is from $4.3 billion in 2024 to $6.14 billion in 2025, having a compound annual growth rate (CAGR) of 42.9%. The historical growth period was driven by factors such as enhanced accessibility to genomic data, the emergence of precision medicine, a surge in the demand for biomarker discovery, optimization of clinical trials, and heightened collaborative efforts.
Expectations are high for escalating growth in the AI in bioinformatics market size over the coming years. The market is projected to expand to “$26.15 billion by 2029, growing at a compound annual growth rate (CAGR) of 43.7%”. This anticipated growth over the forecast period can be ascribed to the advancement of single-cell technologies, an increased emphasis on the integration of multi-omics, a rising focus on functional genomics, and an acceleration of drug repurposing as well as a surge in the utilisation of AI in pathology. Key trends to watch during the forecast period include a focus on ethical AI and responsible data usage, the development of AI-driven virtual labs, an integration of quantum computing, AI-boosted clinical trials, and the use of blockchain for the secure exchange of data.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13774&type=smp
What Forces Are Driving The Growth Of The AI In Bioinformatics Market?
The surge in clinical trial numbers is projected to fuel the expansion of AI in the bioinformatics market. Clinical trials are a meticulously structured method of performing medical research which involves human subjects to assess the safety, efficacy, and potency of new healthcare interventions, treatments, medication, apparatus, or therapeutic tactics. AI in bioinformatics is deployed in these trials to scrutinize patient data acquired from electronic health histories and other resources to determine probable contenders for clinical trials who conform to certain criteria, thereby refining effectiveness of recruitment and specificity. For instance, as reported by Xtalks, a life science and medical apparatus platform based in Canada, in May 2023, ClinicalTrials.gov registered 452,604 clinical trials worldwide, and of these, 64,838 are actively searching for participants. Furthermore, compared to the more than 365,000 registered at the commencement of 2021, registered trials have seen a significant rise. As a result, the escalation in clinical trials is facilitating the progress of AI in the bioinformatics market.
The ai in bioinformatics market covered in this report is segmented –
1) By Type: Machine Learning, Deep Learning, Other Types
2) By Offering: Services, Software
3) By Application: Genomics, Chemoinformatics And Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, Other Applications
Subsegments:
1) By Machine Learning: Supervised Learning Algorithms, Unsupervised Learning Algorithms, Reinforcement Learning
2) By Deep Learning: Neural Networks, Natural Language Processing Models, Generative Adversarial Networks (GANs)
3) By Other Types: Statistical Models, Evolutionary Algorithms, Fuzzy Logic Systems
What Trends Are Currently Influencing Growth In The AI In Bioinformatics Market?
Companies that are key players in the AI in bioinformatics market are utilizing technological advancements on the Bionl.AI platform to enhance their market profitability. Bionl.AI provides a comprehensive workspace for exploration, analysis, and visualization, significantly reducing the time needed to undertake complex tasks. For example, in October 2023, Bionl Inc., an American company specializing in biomedical and bioinformatics research platforms, introduced Bionl.AI. This innovative platform is designed to transform biomedical and bioinformatics research by offering a no-code solution for researchers, students, and professionals to delve into biomedicine using natural language queries. The platform uses advanced GenAI models to provide immediate insights and simplifies complex analysis, making it more interactive and user-friendly.
Which Companies Currently Dominate The Competitive Landscape In The AI In Bioinformatics Industry?
Major companies operating in the AI in bioinformatics market report are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Dassault Systèmes SE, Illumina Inc., NeoGenomics Laboratories Inc., QIAGEN N.V., SomaLogic Operating Co. Inc., Seven Bridges Genomics Inc., Genialis Inc., SOPHiA GENETICS SA, DNAnexus Inc., Insilico Medicine Inc., Deep Genomics Inc., Biomax Informatics Inc., Ardigen SA, Strand Life Sciences Pvt. Ltd., Genomenon Inc., SourceBio International Limited, Fios Genomics Limited, CelbridgeScience, BlueBee Holding BV, JADBio, Elucidata Corporation, Gnosis DA, DNASTAR Inc., iNDX.Ai, Paige AI Inc.
https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report
Which Geographic Regions Are Driving Demand In The AI In Bioinformatics Market?
North America was the largest region in the AI in bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in bioinformatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=13774&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
